CALIFORNIA · LIFE SCIENCES · REGULATORYX

Helping innovative treatments move from science to patients.

RegulatoryX helps biotechnology and pharmaceutical organisations advance innovative medicines through clinical development, regulatory strategy, regulatory writing, data and digital expertise — and the specialist talent needed to deliver.

Discuss your programme ↗Explore capabilities ↓
15+years of industry experience
FDAUS regulatory perspective
Globaldevelopment pathways
DEVELOPMENT PATHWAY●
01ClinicalBuild the evidence
02RegulatoryDefine the route
03DeliveryExecute with control
FocusDecision → Deliverable → Capability
Regulatory Strategy ✓
Clinical Development ✓
Specialist People ✓
CONNECTING — CALIFORNIA AND INDIA✦INDIA AND EUROPE✦CALIFORNIA AND EUROPE✦CONNECTING — CALIFORNIA AND INDIA✦INDIA AND EUROPE✦CALIFORNIA AND EUROPE✦
01 ABOUT REGULATORYX

Experienced people for consequential R&D decisions.

RegulatoryX is a founder-led R&D and specialist resourcing company helping innovative life-sciences teams solve development challenges, execute critical work and build the capability needed to move programmes forward.

Biotechnology and pharmaceutical programmes often need expertise before they need permanent infrastructure. Our approach connects clinical development, regulatory affairs, writing, data and digital execution. We can support a focused decision, lead a defined workstream, work alongside an existing team or help find the right permanent or interim capability.

CaliforniaBiotech & pharmaUS + global pathwaysSenior specialist expertise
02 R&D SERVICES

Connected expertise across the development pathway.

Clinical, regulatory, writing, data and digital decisions rarely happen in isolation. We connect them, so a decision made in one area holds up in the next.

↗
01

Clinical Development

Development strategy, protocol and evidence planning, study-design input and programme decision support.

Explore clinical support →
Aa
03

Regulatory Writing

Scientific and regulatory documents shaped around the objective, audience and evidence.

Explore writing support →
+
06

Specialist Talent

Permanent, executive, contract, interim and project-based professionals selected in programme context.

Discuss talent needs →
03 WHY REGULATORYX

Start with the constraint, not a generic service list.

Senior, hands-on expertise that stays close to the actual work, connected thinking across the development pathway, and engagement that flexes to the need — not the other way round.

See who we help ↗
01

Establish an integrated development and evidence pathway

+
02

Prepare for a pivotal agency interaction or submission

+
03

Resolve a contested dose, endpoint, population or comparator question

+
04

Strengthen the quality and consistency of regulatory documents

+
05

Add senior capability without immediately building permanent overhead

+
04 ENGAGEMENT MODELS

The right model for the actual need.

01

Focused Advisory

A defined question, decision or independent review.

02

Project Delivery

A clear output, timeline and governance model.

03

Fractional & Interim

Experienced leadership embedded for a period or transition.

04

Specialist Team

A coordinated group of experts assembled around a workstream.

05

Permanent Talent

Search support when the capability belongs inside the organisation.

05 EXPERIENCE

Judgement where science, regulation and delivery intersect.

Particular strength across oncology and immuno-oncology, cell and gene therapy, biologics and innovative medicines, rare disease, precision medicine and companion diagnostics, and global clinical development.

OncologyCell & Gene TherapyBiologicsRare DiseasePrecision MedicineGlobal Development
06 INSIGHTS

Latest thinking.

AI ASSURANCE

Why drug-development AI needs expert evaluation — not just impressive demos

Explore insight ↗
BIOTECH OPERATING MODEL

The first 90 days of fractional regulatory leadership

Explore insight ↗

START WITH THE CONSTRAINT

What is slowing your programme — or which capability is your team missing?

Tell us the decision, deliverable or role you are working through. We will help identify the most useful next step.

Start a conversation ↗Explore our capabilities →
REGULATORY STRATEGY✦CLINICAL DEVELOPMENT✦REGULATORY WRITING✦DATA✦DIGITAL R&D✦SPECIALIST TALENT✦REGULATORY STRATEGY✦CLINICAL DEVELOPMENT✦REGULATORY WRITING✦DATA✦DIGITAL R&D✦SPECIALIST TALENT✦